The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues
- PMID: 12436110
- DOI: 10.1038/ni860
The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues
Abstract
Endoplasmic reticulum (ER) aminopeptidase 1 (ERAP1) appears to be specialized to produce peptides presented on class I major histocompatibility complex molecules. We found that purified ERAP1 trimmed peptides that were ten residues or longer, but spared eight-residue peptides. In vivo, ERAP1 enhanced production of an eight-residue ovalbumin epitope from precursors extended on the NH2 terminus that were generated either in the ER or cytosol. Purified ERAP1 also trimmed nearly half the nine-residue peptides tested. By destroying such nine-residue peptides in normal human cells, ERAP1 reduced the overall supply of antigenic peptides. However, after interferon-gamma treatment, which causes proteasomes to produce more NH2-extended antigenic precursors, ERAP1 increased the supply of peptides for MHC class I antigen presentation.
Comment in
-
The final cut: how ERAP1 trims MHC ligands to size.Nat Immunol. 2002 Dec;3(12):1121-2. doi: 10.1038/ni1202-1121. Nat Immunol. 2002. PMID: 12447365 No abstract available.
Similar articles
-
An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides.Nat Immunol. 2002 Dec;3(12):1169-76. doi: 10.1038/ni859. Epub 2002 Nov 18. Nat Immunol. 2002. PMID: 12436109
-
The final cut: how ERAP1 trims MHC ligands to size.Nat Immunol. 2002 Dec;3(12):1121-2. doi: 10.1038/ni1202-1121. Nat Immunol. 2002. PMID: 12447365 No abstract available.
-
Post-proteasomal antigen processing for major histocompatibility complex class I presentation.Nat Immunol. 2004 Jul;5(7):670-7. doi: 10.1038/ni1089. Nat Immunol. 2004. PMID: 15224092 Review.
-
The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules.Nat Immunol. 2006 Jan;7(1):103-12. doi: 10.1038/ni1286. Epub 2005 Nov 20. Nat Immunol. 2006. PMID: 16299505
-
Complexity, contradictions, and conundrums: studying post-proteasomal proteolysis in HLA class I antigen presentation.Immunol Rev. 2005 Oct;207:42-59. doi: 10.1111/j.0105-2896.2005.00313.x. Immunol Rev. 2005. PMID: 16181326 Review.
Cited by
-
ERAP Inhibitors in Autoimmunity and Immuno-Oncology: Medicinal Chemistry Insights.J Med Chem. 2024 Jul 25;67(14):11597-11621. doi: 10.1021/acs.jmedchem.4c00840. Epub 2024 Jul 16. J Med Chem. 2024. PMID: 39011823 Free PMC article. Review.
-
Single-cell genome-wide association reveals that a nonsynonymous variant in ERAP1 confers increased susceptibility to influenza virus.Cell Genom. 2022 Nov 9;2(11):100207. doi: 10.1016/j.xgen.2022.100207. Cell Genom. 2022. PMID: 36465279 Free PMC article.
-
Discovery of Selective Inhibitors of Endoplasmic Reticulum Aminopeptidase 1.J Med Chem. 2020 Jan 9;63(1):103-121. doi: 10.1021/acs.jmedchem.9b00293. Epub 2019 Dec 30. J Med Chem. 2020. PMID: 31841350 Free PMC article.
-
Re-examining class-I presentation and the DRiP hypothesis.Trends Immunol. 2014 Apr;35(4):144-52. doi: 10.1016/j.it.2014.01.002. Epub 2014 Feb 21. Trends Immunol. 2014. PMID: 24566257 Free PMC article. Review.
-
Current and potential immune therapies and vaccines in the management of psoriasis.Hum Vaccin Immunother. 2014;10(4):876-86. doi: 10.4161/hv.27532. Epub 2014 Feb 3. Hum Vaccin Immunother. 2014. PMID: 24492530 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous